Literature DB >> 23949589

Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania.

Myassa Dartell1, Vibeke Rasch, Christian Munk, Crispin Kahesa, Julius Mwaiselage, Thomas Iftner, Susanne Krüger Kjaer.   

Abstract

BACKGROUND: Human papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide. The prevalence is dependent on several known factors notably sexual behavior and age, and factors still under scrutiny.
OBJECTIVE: This study aimed to examine risk factors for high-risk (HR) HPV infection among HIV-positive and HIV-negative women from the general population of Tanzania and to assess whether specific risk factors could contribute to the high prevalence of HR HPV infection in older age found in some populations including Tanzanian women.
METHODS: A cross-sectional study of 3699 women from Tanzania was conducted. We obtained information on sociodemographic and lifestyle factors through personal interview. Cervical swabs were collected for detection of HR HPV (Hybrid Capture 2; Qiagen, Hildesheim, Germany) and genotyping (LiPaExtra; Innogenetics, Gent, Belgium). Finally, we obtained a blood sample for HIV testing.
RESULTS: HIV positivity was the strongest risk factor for HR HPV (odds ratio, 4.1; 95% confidence interval, 3.3-5.3). Young age, shorter duration of present relationship, and increasing number of sex partners were also associated with higher risk for HR HPV. Among women 20 to 29 years old, especially number of partners (P = 0.005) and HIV positivity (P < 0.0001) determined the risk. In underweight women 50 years or older (P = 0.004) and HIV positivity (P = 0.0009) increased the risk, whereas increasing number of partners was not related to the risk of HR HPV (P = 0.46).
CONCLUSIONS: Human papillomavirus risk factors among HIV-positive and HIV-negative women were similar, but the strength of association was greater among HIV-positive women, notably for lifetime number of sex partners, time in present relationship, genital warts, and body mass index. We were not able to identify a clear explanation for the high HPV prevalence among older women. However, in the age-stratified analysis, potential indicators of decreased immunity increased the risk for HPV infection among older women, whereas in younger women, risk was particularly associated with sexual activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23949589     DOI: 10.1097/OLQ.0000000000000005

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

1.  Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.

Authors:  Joel C Boggan; David K Walmer; Gregory Henderson; Nahida Chakhtoura; Schatzi H McCarthy; Harry J Beauvais; Jennifer S Smith
Journal:  Sex Transm Dis       Date:  2015-11       Impact factor: 2.830

2.  Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study.

Authors:  Catherine Ali-Risasi; Kristien Verdonck; Elizaveta Padalko; Davy Vanden Broeck; Marleen Praet
Journal:  Infect Agent Cancer       Date:  2015-07-15       Impact factor: 2.965

3.  A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.

Authors:  Jessica L Castilho; José Eduardo Levi; Paula M Luz; Mary Catherine Cambou; Tazio Vanni; Angela de Andrade; Mônica Derrico; Valdiléa G Veloso; Beatriz Grinsztejn; Ruth K Friedman
Journal:  BMC Cancer       Date:  2015-06-23       Impact factor: 4.430

4.  Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland.

Authors:  Themba G Ginindza; Xolisile Dlamini; Maribel Almonte; Rolando Herrero; Pauline E Jolly; Joyce M Tsoka-Gwegweni; Elisabete Weiderpass; Nathalie Broutet; Benn Sartorius
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

5.  High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.

Authors:  Ralph-Sydney Mboumba Bouassa; Zita Aleyo Nodjikouambaye; Damtheou Sadjoli; Chatté Adawaye; Hélène Péré; David Veyer; Mathieu Matta; Leman Robin; Serge Tonen-Wolyec; Ali Mahamat Moussa; Donato Koyalta; Laurent Belec
Journal:  PLoS One       Date:  2019-06-03       Impact factor: 3.240

Review 6.  Cervical cancer in Tanzania: A systematic review of current challenges in six domains.

Authors:  Ava S Runge; Megan E Bernstein; Alexa N Lucas; Krishnansu S Tewari
Journal:  Gynecol Oncol Rep       Date:  2019-05-21

7.  Comprehensive Cervical Cancer Prevention in Tanzania (CONCEPT) study: Cohort profile.

Authors:  Bariki Mchome; Patricia Swai; Chunsen Wu; Johnson Katanga; Crispin Kahesa; Rachel Manongi; Julius D Mwaiselage; Susanne Kjaer; Vibeke Rasch; Ditte Søndergaard Linde
Journal:  BMJ Open       Date:  2020-09-18       Impact factor: 2.692

8.  Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme.

Authors:  Fidele Ngabo; Silvia Franceschi; Iacopo Baussano; M Chantal Umulisa; Peter J F Snijders; Anne M Uyterlinde; Fulvio Lazzarato; Vanessa Tenet; Maurice Gatera; Agnes Binagwaho; Gary M Clifford
Journal:  BMC Infect Dis       Date:  2016-05-24       Impact factor: 3.090

9.  The characteristics and risk factors of human papillomavirus infection: an outpatient population-based study in Changsha, Hunan.

Authors:  Dabao Xu; Xingping Zhao; Bingsi Gao; Yu-Ligh Liou; Yang Yu; Lingxiao Zou; Waixing Li; Huan Huang; Aiqian Zhang
Journal:  Sci Rep       Date:  2021-07-23       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.